168 related articles for article (PubMed ID: 36417583)
1. Metabolic Recycling Enhances Proliferation in MYC-Transformed Lymphoma B Cells.
Zhang C; Hoang G; Attarwala N; Cooper AJL; Asaka R; Le A
Adv Biol (Weinh); 2023 Feb; 7(2):e2200233. PubMed ID: 36417583
[TBL] [Abstract][Full Text] [Related]
2. Uncovering metabolic reservoir cycles in MYC-transformed lymphoma B cells using stable isotope resolved metabolomics.
Hoang G; Zhang C; Attarwala N; Jung JG; Cooper AJL; Le A
Anal Biochem; 2021 Nov; 632():114206. PubMed ID: 33894159
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis.
Choi UY; Lee JJ; Park A; Zhu W; Lee HR; Choi YJ; Yoo JS; Yu C; Feng P; Gao SJ; Chen S; Eoh H; Jung JU
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8083-8093. PubMed ID: 32213586
[TBL] [Abstract][Full Text] [Related]
4. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer.
Zhang G; Yang P; Guo P; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Aug; 1836(1):49-59. PubMed ID: 23523716
[TBL] [Abstract][Full Text] [Related]
6. Metabolite sensing and signaling in cancer.
Wang YP; Li JT; Qu J; Yin M; Lei QY
J Biol Chem; 2020 Aug; 295(33):11938-11946. PubMed ID: 32641495
[TBL] [Abstract][Full Text] [Related]
7. MYC and metabolism on the path to cancer.
Hsieh AL; Walton ZE; Altman BJ; Stine ZE; Dang CV
Semin Cell Dev Biol; 2015 Jul; 43():11-21. PubMed ID: 26277543
[TBL] [Abstract][Full Text] [Related]
8. Untargeted metabolomics and lipidomics analysis identified the role of FOXA1 in remodeling the metabolic pattern of BaP-transformed 16HBE cells.
Zhou C; Ma X; Chen J; Li L; Wang Y; Xing Y; Fu J; Yao B; Chang B; Zhao P
Toxicol Appl Pharmacol; 2021 Sep; 426():115640. PubMed ID: 34242566
[TBL] [Abstract][Full Text] [Related]
9. Measuring MYC-Mediated Metabolism in Tumorigenesis.
Tang HY; Goldman AR; Zhang X; Speicher DW; Dang CV
Methods Mol Biol; 2021; 2318():231-239. PubMed ID: 34019293
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Codependencies in the Tumor Microenvironment.
Dey P; Kimmelman AC; DePinho RA
Cancer Discov; 2021 May; 11(5):1067-1081. PubMed ID: 33504580
[TBL] [Abstract][Full Text] [Related]
11. Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis.
Nilsson LM; Forshell TZ; Rimpi S; Kreutzer C; Pretsch W; Bornkamm GW; Nilsson JA
PLoS Genet; 2012; 8(3):e1002573. PubMed ID: 22438825
[TBL] [Abstract][Full Text] [Related]
12. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
Högstrand K; Grandien A
Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
[TBL] [Abstract][Full Text] [Related]
13. Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone.
Xie J; Zhang AH; Qiu S; Zhang TL; Li XN; Yan GL; Sun H; Liu L; Wang XJ
J Proteomics; 2019 Aug; 206():103447. PubMed ID: 31326558
[TBL] [Abstract][Full Text] [Related]
14.
AlMalki RH; Sebaa R; Al-Ansari MM; Al-Alwan M; Alwehaibi MA; Rahman AMA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835626
[TBL] [Abstract][Full Text] [Related]
15. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes strike a balance between cellular growth and homeostasis.
Qiu B; Simon MC
Semin Cell Dev Biol; 2015 Jul; 43():3-10. PubMed ID: 26277544
[TBL] [Abstract][Full Text] [Related]
17. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA KTN1-AS1 co-regulates a variety of Myc-target genes and enhances proliferation of Burkitt lymphoma cells.
Winkle M; Tayari MM; Kok K; Duns G; Grot N; Kazimierska M; Seitz A; de Jong D; Koerts J; Diepstra A; Dzikiewicz-Krawczyk A; Steidl C; Kluiver J; van den Berg A
Hum Mol Genet; 2022 Dec; 31(24):4193-4206. PubMed ID: 35866590
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.
Fish K; Chen J; Longnecker R
Blood; 2014 Jan; 123(4):530-40. PubMed ID: 24174629
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]